Probing the metabolic regulator and candidate tumor suppressor ALDH1L1 as a target for non-small cell lung cancer gene therapy.

Although data from Figure 1 C did not reach statistical significance, which is a common occurrence for a small group size analysis, they indicate the link between ALDH1L1 expression and outcomes in patients with LUADs.

also in 111,027 other papers